RESULTS FOR : 'Stratification'
Showing 1 to 2 of 2 results |    
Keyword Search
Show#
Show#
Results Category/Section
Breath based biomarker detection - informing drug development and future treatment regimes

The recent approval of the first liquid biopsy test for the diagnosis of non-small cell lung cancer (NSCLC) demonstrates how biomarker-based detection tools are becoming important components of precision medicine-based drug treatment regimes.

Individualised Systems Medicine next-generation precision cancer medicine and drug positioning.

A growing number of oncology drugs are currently clinically available and more than a thousand compounds are being developed for oncology indications.